Business
Share Buyback & Completion of Buyback Programme
EKF Diagnostics Holdings plc has successfully completed its share buyback programme, purchasing a total of 17,130,678 ordinary shares at a weighted average cost of 26.14 pence per share. The most recent transaction on January 30, 2026, involved the acquisition of 159,000 shares at an average price of 25.6875 pence, with these shares to be held in treasury. Following these purchases, the company's total voting rights stand at 431,963,112. Notably, a portion of the buyback involved 47,000 shares acquired from entities associated with Non-Executive Director Christopher Mills, ensuring his indirect beneficial interest remains below 30%. Disclaimer*
About this update from Ekf Diagnostics Holdings Plc
[{"type":"text","content":"\n\n \n \nEKF Diagnostics Holdings plc\n(\"EKF\" or the \"Company\")\n \nShare Buyback\n& Completion of Share Buyback Programme\n \nEKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that it has purchased a total of 159,000 of its ordinary shares of 1p each in the capital of the Company (\"Ordinary Shares\") at a weighted average price of 25.6875 pence per share. The Ordinary Shares purchased will be held in treasury.\n \nThis transaction marks the successful conclusion of the share buyback programme announced on 21 May 2025 and the subsequent extension as set out in the announcement on 21 October 2025. Pursuant to the share buyback programme, a total of 17,130,678 ordinary shares were purchased at a weighted average cost of 26.14 pence per Ordinary Share.\n \n \nAggregated information\n \n\n\n\n\nDate of purchase\n\n\n30 January 2026\n\n\n\n\nNumber of Ordinary Shares purchased\n\n\n159,000\n\n\n\n\nHighest price paid per Ordinary Share\n\n\n25.8000p\n\n\n\n\nLowest price paid per Ordinary Share\n\n\n25.5000p\n\n\n\n\nVolume weighted average price paid\n\n\n25.6875p\n\n\n\n\n \n Transaction details\n \nIn accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018), a detailed breakdown of individual trades is available below:\n \n\n\n\n\nNumber of Ordinary Shares purchased\n\n\nTransaction price (GBp)\n\n\nTime of transaction\n\n\nTrading venue\n\n\n\n\n25,000\n\n\n25.8000p\n\n\n10:10:25\n\n\nAIMX\n\n\n\n\n45,000\n\n\n25.8000p\n\n\n11:44:21\n\n\nAIMX\n\n\n\n\n42,000\n\n\n25.5000p\n\n\n11:51:53\n\n\nAIMX\n\n\n\n\n47,000\n\n\n25.6875p\n\n\n15:37:38\n\n\nAIMX\n\n\n\n\n \nTotal voting rights\n \nFollowing the purchase, the Company's total issued share capital will consist of 435,383,092 Ordinary Shares, of which 3,419,980 Ordinary Shares are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights will be 431,963,112. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Com...